Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Edirol and eldecalcitolum. Its PubChem CID is 6918141.
Eldecalcitol
| CAS No | 104121-92-8 |
|---|---|
| Molecular Formula | C30H50O5 |
| Molecular Weight | 490.7 g/mol |
| Synonyms | (1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation.
The listed CAS number is 104121-92-8.
The listed molecular formula is C30H50O5.
The listed molecular weight is 490.7 g/mol.
(1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol.
The source lists Edirol and eldecalcitolum.